As Saudi Arabia moves toward healthcare self-sufficiency under Vision 2030, the localization of vital pharmaceutical manufacturing has become a critical priority. In a major step forward, Sanofi, ...

Saudi-based Sudair Pharma Company is set to establish its new insulin plant in the Sudair City for Industry and Businesses.

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Bausch Health Companies Inc.

These ten new MoUs follow NUPCO’s recent agreements with global pharmaceutical leaders, including Novo Nordisk (Denmark) and ...

Market OverviewThe Orphan Drugs Market is a specialized sector within the pharmaceutical industry that focuses on the ...

Global war fears are rising among experts around the world, with more than 40 percent expecting a new world conflict in the ...

Climate-driven extreme weather disasters and resource conflicts can intensify social and political rifts both domestically ...

If approved, Sanofi will commercialise the vaccines worldwide except for South Korea, where SK Bioscience will have exclusive rights. According to Evaluate Pharma data from June, the global ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

The forceful Realpolitik application of U.S. trade policies and tariff threats is intended to support U.S. national security ...